# Parcopa Versus Carbidopa-levodopa in a Single Dose Cross-over Comparison Study

> **NCT00590122** · PHASE4 · COMPLETED · sponsor: **Baylor College of Medicine** · enrollment: 20 (actual)

## Conditions studied

- Parkinson's Disease

## Interventions

- **DRUG:** Parcopa
- **DRUG:** carbidopa-levodopa (Sinemet)

## Key facts

- **NCT ID:** NCT00590122
- **Lead sponsor:** Baylor College of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-10
- **Primary completion:** 2008-10
- **Final completion:** 2008-11
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2023-03-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00590122

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00590122, "Parcopa Versus Carbidopa-levodopa in a Single Dose Cross-over Comparison Study". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00590122. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*